Levofolino Rugštis Medac

Levoleucovorin Disodium, the active ingredient in Levofolino Rugštis Medac, is a folate analog presented as a sterile powder for intravenous use. It is employed to rescue patients from the toxic effects of high‑dose methotrexate and other antifolate chemotherapies, supporting normal cell recovery during cancer treatment.

GNH USA supplies Levofolino Rugštis Medac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide. The company follows stringent quality standards and provides full regulatory documentation to facilitate global distribution and import compliance.

Levoleucovorin Disodium is used in oncology to mitigate toxicity associated with antifolate chemotherapy.

- Rescue therapy after high‑dose methotrexate: reduces methotrexate‑induced toxicity and promotes rapid recovery of normal cells. - Antifolate chemotherapy toxicity reduction: lessens adverse effects of agents such as pemetrexed and carmustine. - Adjunct to 5‑fluorouracil‑based regimens: enhances therapeutic efficacy while decreasing gastrointestinal and hematologic side effects.

Levoleucovorin Disodium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Rash: mild erythematous skin changes. - Elevated liver enzymes: temporary increase in hepatic transaminases.

Serious or Rare Side Effects: - Acute renal failure: sudden loss of kidney function. - Severe hypersensitivity or anaphylaxis: life‑threatening allergic reaction. - Hepatic dysfunction: marked liver injury or jaundice. - Bone marrow suppression: pancytopenia or severe neutropenia.

When using Levofolino Rugštis Medac, several safety considerations should be observed.

- Renal function: assess baseline kidney status and monitor during therapy. - Hepatic impairment: evaluate liver enzymes before and after administration. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Concomitant methotrexate timing: ensure appropriate interval to achieve rescue effect. - Allergy: discontinue immediately if signs of hypersensitivity appear. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levoleucovorin Disodium can interact with other medicines, influencing efficacy or toxicity.

Major Interactions (Avoid): - Methotrexate: improper timing may diminish rescue efficacy. - Cytarabine: concurrent use can increase cytotoxicity. - High‑dose folate antagonists: may reduce therapeutic effect of Levoleucovorin.

Moderate Interactions (Monitor Closely): - NSAIDs: may affect renal clearance of the drug. - Penicillins: possible reduction in folate levels. - Trimethoprim: additive folate antagonism may increase toxicity.